Cytokine production capacity in depression and anxiety
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested that immune function may be dysregulated in persons with depressive and anxiety disorders. Few studies examined the expression of cytokines in response to ex vivo stimulation of blood by lipopolysaccharide (LPS) to study the innate production capacity of cytokines in depression and anxiety. To investigate this, baseline data from the Netherlands Study of Depression and Anxiety (NESDA) were used, including persons (18–65 years; 66% women) with current (that is, past month; N=591) or remitted (N=354) DSM-IV depressive or anxiety disorders and healthy controls (N=297). Depressive and anxiety symptoms were measured by means of the Inventory of Depressive Symptomatology (IDS) and the Beck Anxiety Inventory (BAI). Using Multi-Analyte Profiling technology, plasma levels of 13 cytokines were assayed after whole blood stimulation by addition of LPS. Basal plasma levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α were also available. A basal and a LPS summary index were created. Results show that LPS-stimulated inflammation was associated with increased odds of current depressive/anxiety disorders (odds ratio (OR)=1.28, P=0.009), as was the case for basal inflammation (OR=1.28, P=0.001). These associations were no longer significant after adjustment for lifestyle and health (OR=1.13, P=0.21; OR=1.07, P=0.45, respectively). After adjustment for lifestyle and health, interleukin-8 was associated with both remitted (OR=1.25, P=0.02) and current (OR=1.28, P=0.005) disorders. In addition, LPS-stimulated inflammation was associated with more severe depressive (β=0.129, P<0.001) and anxiety (β=0.165, P<0.001) symptoms, as was basal inflammation. Unlike basal inflammation, LPS-stimulated inflammation was still associated with (anxiety) symptom severity after adjustment for lifestyle and health (IDS: interleukin (IL)-8, MCP-1, MMP2; BAI: LPS index, IL-6, IL-8, IL-10, IL-18, MCP-1, MMP2, TNF-β). To conclude, lifestyle and health factors may partly explain higher levels of basal, as well as LPS-stimulated inflammation in persons with depressive and anxiety disorders. However, production capacity of several cytokines was positively associated with severity of depressive and in particular anxiety symptoms, even while taking lifestyle and health factors into account. Elevated IL-8 production capacity in both previously and currently depressed and anxious persons might indicate a genetic vulnerability for these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Cited by
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Self-citationImmune targets for therapeutic development in depression: towards precision medicine
Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., & Manji, H. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00368-1 · Cited by 348
Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y.-K., & Jeon, H. J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 304
Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases
Regueiro, M., Greer, J. B., & Szigethy, E. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.036 · Cited by 142
Lasselin, J., Lekander, M., Axelsson, J., & Karshikoff, B. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.06.005 · Cited by 106
Callaghan, B. L., Fields, A., Gee, D. G., Gabard-Durnam, L., Caldera, C., Humphreys, K. L., Goff, B., Flannery, J., Telzer, E. H., Shapiro, M., et al. (2020) · Development and Psychopathology · doi:10.1017/s0954579419000087 · Cited by 93
Mayerhofer, R., Fröhlich, E. E., Reichmann, F., Farzi, A., Kogelnik, N., Fröhlich, E., Sattler, W., & Holzer, P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.10.011 · Cited by 89
Costi, S., Morris, L. S., Collins, A., Fernandez, N. F., Patel, M., Xie, H., Kim-Schulze, S., Stern, E. R., Collins, K. A., Cathomas, F., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01668-1 · Cited by 87
Karlsson, L., Nousiainen, N., Scheinin, N. M., Maksimow, M., Salmi, M., Lehto, S. M., Tolvanen, M., Lukkarinen, H., & Karlsson, H. (2017) · Archives of Women's Mental Health · doi:10.1007/s00737-016-0672-y · Cited by 85
“Thus, elevations in the levels of both Th1 and Th2 cytokines, as well as in pleiotrophic cytokines such as IL-8 (Vogelzangs et al. 2016), have been observed in individuals with depression.”
BackgroundThe Role of Anxious Distress in Immune Dysregulation in Patients with Major Depressive Disorder
Gaspersz, R., Lamers, F., Wittenberg, G., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0016-3 · Cited by 71
Self-citationPsychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Interleukin-6 and Interleukin-10 in Mood Disorders: A Population-Based Study
Wiener, C. D., Moreira, F. P., Portela, L. V., Strogulski, N. R., Lara, D. R., da Silva, R. A., Souza, L. D. D. M., Jansen, K., & Oses, J. P. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.100 · Cited by 68
Wiebenga, J. X. M., Heering, H. D., Eikelenboom, M., van Hemert, A. M., van Oppen, P., & Penninx, B. W. J. H. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.021 · Cited by 53
Self-citationInterleukin-10 Level Is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients
Chi, C.-H., Huang, Y.-Y., Ye, S.-Z., Shao, M.-M., Jiang, M.-X., Yang, M.-Y., Wu, Q., Shao, B., & Li, X.-M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.037 · Cited by 50
Mello, B. S. F., Chaves Filho, A. J. M., Custódio, C. S., Cordeiro, R. C., Miyajima, F., de Sousa, F. C. F., Vasconcelos, S. M. M., de Lucena, D. F., & Macedo, D. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.009 · Cited by 45
Strawn, J. R., & Levine, A. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100024 · Cited by 30
Serum levels of chemokines in adolescents with major depression treated with fluoxetine.
Peña, F. R. D. L., Cruz-Fuentes, C., Palacios, L., Girón-Pérez, M. I., Medina-Rivero, E., Ponce-Regalado, M. D., Alvarez-Herrera, S., Pérez-Sánchez, G., Becerril-Villanueva, E., Maldonado-García, J. L., et al. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i8.175 · Cited by 24
Yrondi, A., Aouizerate, B., El-Hage, W., Moliere, F., Thalamas, C., Delcourt, N., Sporer, M., Taib, S., Schmitt, L., Arlicot, N., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00326 · Cited by 19
Dragasevic, S., Stankovic, B., Kotur, N., Sokic Milutinovic, A., Nikolic, A., Pavlovic, S., & Popovic, D. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae180 · Cited by 13
Depression-Associated Cellular Components of the Innate and Adaptive Immune System
Ahmetspahic, D., Brinker, D., & Alferink, J. (2018) · Inflammation and Immunity in Depression · doi:10.1016/b978-0-12-811073-7.00001-5 · Cited by 3
Liu, J., Lu, Y., Bhuiyan, P., Gruttner, J., St. Louis, L., Yi, Y., Liang, G., & Wei, H. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03816-x · Cited by 2
Metadata
- Authors
- Vogelzangs, N., de Jonge, P., Smit, J. H., Bahn, S., & Penninx, B. W.
- Venue
- Translational Psychiatry
- Published
- 2016-05-31
- Volume
- 6
- Issue
- 5
- Pages
- e825-e825
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2411655855
- Cited by
- 193
- References
- 29
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.